Skip to main content
MONROE / INDEPENDENT RESEARCH CATALOGUENot sure where to begin? Use guided discovery
Currency
Shop0Find my pathway

Search Peptipedia.

Ask a question or explore a peptide. Read a plain-language explanation, then follow its sources for more detail.

Explore the research.

6 source papers

Original source papers

  1. 2026 JanDiabetes, obesity & metabolism

    Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trials.

    Giblin K, Kaplan LM, Somers VK et al.

  2. 2025 AugThe lancet. Diabetes & endocrinology

    Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial.

    Coskun T, Wu Q, Schloot NC et al.

  3. 2025 May 30Biomolecules

    Retatrutide-A Game Changer in Obesity Pharmacotherapy.

    Katsi V, Koutsopoulos G, Fragoulis C et al.

  4. 2024 Dec 15European journal of pharmacology

    The power of three: Retatrutide's role in modern obesity and diabetes therapy.

    Abdul-Rahman T, Roy P, Ahmed FK et al.

  5. 2024 JulNature medicine

    Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial.

    Sanyal AJ, Kaplan LM, Frias JP et al.

  6. 2022 Sep 6Cell metabolism

    LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept.

    Coskun T, Urva S, Roell WC et al.